Back to All Events

Lecture: Dr. Robin Carthart-Harris




Dr. Robin Carhart-Harris is considered one of todays leading scientist on psychedelics. The German Psychedelic Society is pleased to announce that Dr. Carhart-Harris will give a talk about his research November 24th in Berlin. 

LOCATION: To be announced

Carhart-Harris designed and coordinated the first fMRI and MEG research with psilocybin and LSD, the first resting-state fMRI research with MDMA and the first clinical trial to investigate a psychedelic (psilocybin) in the treatment of depression. He has close to 40 published papers (over 20 are ‘first author’ papers, including papers in PNAS (x2), Lancet Psychiatry, Biological Psychiatry and Brain) and he is increasingly publishing as senior author (e.g.Current Biology, Human Brain Mapping (x3)). His research has been featured in major national and international media (e.g. The New Yorker, BBC Newsnight, TIME and CNN)


Robin has been conducting pioneering brain imaging studies of psychedelic drugs. Most recently, he has completed the first phase of a clinical trial looking at the potential of psilocybin to treat depression, and his talk looks at how these drugs can be used in treatment.